Playback speed
10 seconds
This video is featured in the 2024 ASCO® Annual Meeting Insights Hub
ASCO® 2024 Insights: "FIREFLY-1 Trial - Type II RAF Inhibitor Tovorafenib in R/R Pediatric Low Grade Glioma"
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
David Ziegler
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
David Ziegler
145 views
July 11, 2024
Comments 0
Login to view comments.
Click here to Login
2024 ASCO® Annual Meeting Insights Hub: Head & Neck Videos
Recommended
AUTOPLAY